Study of the Toxic Manifestation of Etoposide the Concomitant Exposure of Acetyl Salicylic Acid As a Protector on the Example of C57Bl/6J Mice Line

The paper presents the results of evaluating the genetic and cytogenetic toxicity of etoposide, as well as the evaluation results of protective properties of aspirin against the toxicity of etoposide in C57Bl/6J mice. The cytogenetic activity and protective properties assessment was carried out usin...

Full description

Saved in:
Bibliographic Details
Main Authors: O. N. Antosyuk, A. V. Gorskaya, D. V. Petrovskii, T. D. Dubatolova
Format: Article
Language:Russian
Published: LLC "Publishing House OKI" 2023-10-01
Series:Антибиотики и Химиотерапия
Subjects:
Online Access:https://www.antibiotics-chemotherapy.ru/jour/article/view/1047
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849693086039408640
author O. N. Antosyuk
A. V. Gorskaya
D. V. Petrovskii
T. D. Dubatolova
author_facet O. N. Antosyuk
A. V. Gorskaya
D. V. Petrovskii
T. D. Dubatolova
author_sort O. N. Antosyuk
collection DOAJ
description The paper presents the results of evaluating the genetic and cytogenetic toxicity of etoposide, as well as the evaluation results of protective properties of aspirin against the toxicity of etoposide in C57Bl/6J mice. The cytogenetic activity and protective properties assessment was carried out using the chromosome aberration analysis in metaphase cells. Etoposide was tested at a concentration of 15 and 3 mg/kg and aspirin — at a concentration of 25 mg/kg of the animal. The results of metaphase analysis showed that etoposide exhibits cytogenetic toxicity in both doses, and aspirin exhibits protective properties against the toxicity of etoposide at a concentration of 15 mg/kg. The results of chromosome analysis regarding the protective properties of aspirin against etoposide at a concentration of 3 mg/kg are ambiguous and require further experiments.
format Article
id doaj-art-0a2d4958416f467e98d3daaec5aa183c
institution DOAJ
issn 0235-2990
language Russian
publishDate 2023-10-01
publisher LLC "Publishing House OKI"
record_format Article
series Антибиотики и Химиотерапия
spelling doaj-art-0a2d4958416f467e98d3daaec5aa183c2025-08-20T03:20:32ZrusLLC "Publishing House OKI"Антибиотики и Химиотерапия0235-29902023-10-01685-6333810.37489/0235-2990-2023-68-5-6-33-38969Study of the Toxic Manifestation of Etoposide the Concomitant Exposure of Acetyl Salicylic Acid As a Protector on the Example of C57Bl/6J Mice LineO. N. Antosyuk0A. V. Gorskaya1D. V. Petrovskii2T. D. Dubatolova3Ural Federal University named after the first President of Russia B. N. YeltsinUral Federal University named after the first President of Russia B. N. YeltsinFederal Research Center «Institute of Cytology and Genetics» of the Siberian Branch of the Russian Academy of Sciences; Institute of Systematics and Ecology of Animals of the Siberian Branch of the Russian Academy of SciencesInstitute of Molecular and Cellular Biology of the Siberian Branch of the Russian Academy of SciencesThe paper presents the results of evaluating the genetic and cytogenetic toxicity of etoposide, as well as the evaluation results of protective properties of aspirin against the toxicity of etoposide in C57Bl/6J mice. The cytogenetic activity and protective properties assessment was carried out using the chromosome aberration analysis in metaphase cells. Etoposide was tested at a concentration of 15 and 3 mg/kg and aspirin — at a concentration of 25 mg/kg of the animal. The results of metaphase analysis showed that etoposide exhibits cytogenetic toxicity in both doses, and aspirin exhibits protective properties against the toxicity of etoposide at a concentration of 15 mg/kg. The results of chromosome analysis regarding the protective properties of aspirin against etoposide at a concentration of 3 mg/kg are ambiguous and require further experiments.https://www.antibiotics-chemotherapy.ru/jour/article/view/1047etoposideacetylsalicylic acidc57bl / 6j miceprotective propertiescytogenetic toxicitychromosomal aberrations
spellingShingle O. N. Antosyuk
A. V. Gorskaya
D. V. Petrovskii
T. D. Dubatolova
Study of the Toxic Manifestation of Etoposide the Concomitant Exposure of Acetyl Salicylic Acid As a Protector on the Example of C57Bl/6J Mice Line
Антибиотики и Химиотерапия
etoposide
acetylsalicylic acid
c57bl / 6j mice
protective properties
cytogenetic toxicity
chromosomal aberrations
title Study of the Toxic Manifestation of Etoposide the Concomitant Exposure of Acetyl Salicylic Acid As a Protector on the Example of C57Bl/6J Mice Line
title_full Study of the Toxic Manifestation of Etoposide the Concomitant Exposure of Acetyl Salicylic Acid As a Protector on the Example of C57Bl/6J Mice Line
title_fullStr Study of the Toxic Manifestation of Etoposide the Concomitant Exposure of Acetyl Salicylic Acid As a Protector on the Example of C57Bl/6J Mice Line
title_full_unstemmed Study of the Toxic Manifestation of Etoposide the Concomitant Exposure of Acetyl Salicylic Acid As a Protector on the Example of C57Bl/6J Mice Line
title_short Study of the Toxic Manifestation of Etoposide the Concomitant Exposure of Acetyl Salicylic Acid As a Protector on the Example of C57Bl/6J Mice Line
title_sort study of the toxic manifestation of etoposide the concomitant exposure of acetyl salicylic acid as a protector on the example of c57bl 6j mice line
topic etoposide
acetylsalicylic acid
c57bl / 6j mice
protective properties
cytogenetic toxicity
chromosomal aberrations
url https://www.antibiotics-chemotherapy.ru/jour/article/view/1047
work_keys_str_mv AT onantosyuk studyofthetoxicmanifestationofetoposidetheconcomitantexposureofacetylsalicylicacidasaprotectorontheexampleofc57bl6jmiceline
AT avgorskaya studyofthetoxicmanifestationofetoposidetheconcomitantexposureofacetylsalicylicacidasaprotectorontheexampleofc57bl6jmiceline
AT dvpetrovskii studyofthetoxicmanifestationofetoposidetheconcomitantexposureofacetylsalicylicacidasaprotectorontheexampleofc57bl6jmiceline
AT tddubatolova studyofthetoxicmanifestationofetoposidetheconcomitantexposureofacetylsalicylicacidasaprotectorontheexampleofc57bl6jmiceline